BioCentury
ARTICLE | Company News

Neurotech licenses Amgen's CNTF

January 14, 2002 8:00 AM UTC

Neurotech (Paris, France) obtained an exclusive license to ciliary neurotrophic factor ( CNTF) from AMGN for ophthalmic indications. AMGN will receive Neurotech warrants, and Neurotech will receive upfront payments and milestones, and is eligible for royalties. ...